170 related articles for article (PubMed ID: 28500728)
1. Immunolocalization of Substance P and NK-1 Receptor in ADIPOSE Stem Cells.
Muñoz M; Muñoz MF; Ayala A
J Cell Biochem; 2017 Dec; 118(12):4686-4696. PubMed ID: 28500728
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of NK-1 receptor and Substance P in human normal placenta.
Muñoz M; Pavón A; Rosso M; Salinas MV; Pérez A; Carranza A; González-Ortega A
Placenta; 2010 Jul; 31(7):649-51. PubMed ID: 20430440
[TBL] [Abstract][Full Text] [Related]
3. Substance P enhances proliferation and paracrine potential of adipose-derived stem cells in vitro.
Kim S; Piao J; Son Y; Hong HS
Biochem Biophys Res Commun; 2017 Mar; 485(1):131-137. PubMed ID: 28192115
[TBL] [Abstract][Full Text] [Related]
4. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalization of substance P and NK-1 receptor in Hofbauer cells in human normal placenta.
Muñoz M; Carranza A; Pavón A; Anderson G; Coveñas R
Microsc Res Tech; 2013 Dec; 76(12):1310-3. PubMed ID: 24155270
[TBL] [Abstract][Full Text] [Related]
6. Substance P enhances the local activation of NK
Jeong YM; Cheng XW; Lee KH; Lee S; Cho H; Kim W
BMC Mol Cell Biol; 2020 Jun; 21(1):41. PubMed ID: 32517655
[TBL] [Abstract][Full Text] [Related]
7. Normative distribution of substance P and its tachykinin neurokinin-1 receptor in the medullary serotonergic network of the human infant during postnatal development.
Bright FM; Byard RW; Vink R; Paterson DS
Brain Res Bull; 2018 Mar; 137():319-328. PubMed ID: 29331576
[TBL] [Abstract][Full Text] [Related]
8. Role of neurogenic substance P in overexpression of alveolar macrophages' neurokinin 1 receptor in mice exposed to cigarette smoke.
Xu J; Xu F
Exp Lung Res; 2010 May; 36(4):243-54. PubMed ID: 20426532
[TBL] [Abstract][Full Text] [Related]
9. Localization of neurokinin 1 receptor (NK1R) immunoreactivity in rat esophagus.
Kuramoto H; Oomori Y; Murabayashi H; Kadowaki M; Karaki S; Kuwahara A
J Comp Neurol; 2004 Oct; 478(1):11-21. PubMed ID: 15334646
[TBL] [Abstract][Full Text] [Related]
10. Substance P and the neurokinin-1 receptor expression in dog ileum with and without inflammation.
Polidoro G; Giancola F; Fracassi F; Pietra M; Bettini G; Asti M; Chiocchetti R
Res Vet Sci; 2017 Oct; 114():297-307. PubMed ID: 28628846
[TBL] [Abstract][Full Text] [Related]
11. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice.
Li Q; Wu X; Yang Y; Zhang Y; He F; Xu X; Zhang Z; Tao L; Luo C
Int J Biochem Cell Biol; 2019 Feb; 107():154-165. PubMed ID: 30593954
[TBL] [Abstract][Full Text] [Related]
12. Substance P and the Neurokinin-1 Receptor: The New CRF.
Schank JR; Heilig M
Int Rev Neurobiol; 2017; 136():151-175. PubMed ID: 29056150
[TBL] [Abstract][Full Text] [Related]
13. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
14. NK1R/5-HT1AR interaction is related to the regulation of melanogenesis.
Wu H; Zhao Y; Huang Q; Cai M; Pan Q; Fu M; An X; Xia Z; Liu M; Jin Y; He L; Shang J
FASEB J; 2018 Jun; 32(6):3193-3214. PubMed ID: 29430989
[TBL] [Abstract][Full Text] [Related]
15. Relationship between neurokinin-1 receptor and substance P in the striatum: light and electron microscopic immunohistochemical study in the rat.
Li JL; Wang D; Kaneko T; Shigemoto R; Nomura S; Mizuno N
J Comp Neurol; 2000 Mar; 418(2):156-63. PubMed ID: 10701441
[TBL] [Abstract][Full Text] [Related]
16. Extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase, through nuclear factor-kappaB and activator protein-1, contribute to caerulein-induced expression of substance P and neurokinin-1 receptors in pancreatic acinar cells.
Koh YH; Tamizhselvi R; Bhatia M
J Pharmacol Exp Ther; 2010 Mar; 332(3):940-8. PubMed ID: 20007404
[TBL] [Abstract][Full Text] [Related]
17. Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors.
Palma C; Nardelli F; Manzini S; Maggi CA
Br J Cancer; 1999 Jan; 79(2):236-43. PubMed ID: 9888463
[TBL] [Abstract][Full Text] [Related]
18. Substance P Promotes the Proliferation, but Inhibits Differentiation and Mineralization of Osteoblasts from Rats with Spinal Cord Injury via RANKL/OPG System.
Liu HJ; Yan H; Yan J; Li H; Chen L; Han LR; Yang XF
PLoS One; 2016; 11(10):e0165063. PubMed ID: 27764190
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities in substance P neurokinin-1 receptor binding in key brainstem nuclei in sudden infant death syndrome related to prematurity and sex.
Bright FM; Vink R; Byard RW; Duncan JR; Krous HF; Paterson DS
PLoS One; 2017; 12(9):e0184958. PubMed ID: 28931039
[TBL] [Abstract][Full Text] [Related]
20. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
